Pfizer has recently filed lawsuits against the operators of five websites for selling an unapproved copy of Pfizer’s top selling cholesterol medicine, Lipitor.
The suits were filed in US district courts in Delaware and Connecticut against Generic Lipitors, Online Rx DrugStore, WorldMedsRX, BM International, and Offshore Pharma.
Pfizer said the sites market a product called Storvas, which is advertised as being manufactured by Ranbaxy Pharmaceuticals of India . The lawsuits seek injunctions against further sales of Storvas and claim damages for infringement of Pfizer’s patent and trademark rights for Lipitor.
The complaints also seek to remove references to Lipitor in advertising materials and to eliminate computer links that misdirect patients to an illegal, unapproved product.